MedPath

Safety and efficacy assessment of Product on ski

Not Applicable
Completed
Registration Number
CTRI/2022/03/040715
Lead Sponsor
Kama Ayurveda Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
33
Inclusion Criteria

1. Having dull skin and uneven skin tone

2. Having pigmentary spot on the face of grade 2 to grade 6 according to the Bazins atlas

3. Having Crows feet wrinkle of grade 2 and above according to the Bazins atlas

4. Having visible under eye dark circle

5. Presenting Fitzpatrick skin type III to V with chromameter i.e. ITA° value between -30° &

41° on cheek bones.

Exclusion Criteria

1. Having started, changed or interrupted one hormonal treatment during the past 3 months

2. Having started, changed or stopped her tobacco consumption in the previous 6 months

3. Having consumed caffeine-based products, alcohol, highly spiced food and/or not smoke in the two hours preceding the measurements

4. Having taken a medicinal treatment which could lead to hyper pigmentation in the previous 6 months

5. Taking oral supplements with major or minor effect on whitening of skin

6. Having had beauty treatment e.g. skin cleansing, exfoliation, scrub, mask or having applied self tanning products in the week preceding the start of the study

7. Having applied products with anti-wrinkle action in the 2 weeks preceding the start of the study

8. Having applied products with a depigmenting/ whitening action in the 4 weeks preceding the start of the study

9. Having undergone physical and/or chemical treatments of the spots in the previous 6 months

10. Having a suntanned skin on the studied areas which could interfere with the evaluations of the study For males, having not shaved their beard 24 hours prior to the day of measurement

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Even skin tone, <br/ ><br>reduction in pigmentation (dark spot), radiant skin and skin brightness, safety of a skinTimepoint: Baseline, 14 days and 28 days
Secondary Outcome Measures
NameTimeMethod
Minimize fine <br/ ><br>lines, smooth skin texture, reducing dark circles and improvement in skin hydrationTimepoint: baseline, 14 days and 28 days
© Copyright 2025. All Rights Reserved by MedPath